Ozempic Goes Generic in Canada, Prices to Drop
Semaglutide, sold as Ozempic, is now off-patent in Canada. This move could slash costs by up to 75%, dramatically increasing access to the popular diabetes and weight-loss drug for Canadians.
Category : Pharmaceuticals
AI Partnership Aims to Design Clinical Trials in One Day
Citeline and Risklick partner to transform clinical trial design with AI, aiming to reduce costly amendments and accelerate drug development timelines for Canadian researchers.
1.5M U.S. Patients Using Compounded GLP-1 Drugs: Novo CEO
The CEO of Novo Nordisk disclosed that an estimated 1.5 million Americans are using compounded versions of GLP-1 drugs. Learn about the market implications and safety concerns.
Novo CEO: Obesity Pill Opens Doors to New Markets
Novo Nordisk's CEO says its new obesity pill will tap into millions not using GLP-1s due to needle fears. The drugmaker battles Eli Lilly and compounders in a massive market.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Fake Erectile Dysfunction Drugs Found in Mississauga
Health Canada issues a public warning about counterfeit Viagra and Cialis tablets found at a Mississauga distributor. Learn how to identify fake medications and protect your health.
First Alzheimer's Fighting Infusion Delivered in Canada
A newly approved Alzheimer's drug has been administered for the first time in Canada, providing fresh hope to patients. However, significant questions about coverage costs remain unresolved.
Kilos Return Fast After Stopping Weight-Loss Drugs: Study
New research shows patients quickly regain weight after ending GLP-1 medications like Wegovy. Experts stress the need for long-term lifestyle strategies. Learn the findings.
Ozempic price drop in Quebec after patent expiry
Generic versions of weight-loss drug Ozempic could slash costs from $400 to under $100 per month in Quebec following a key patent expiration, potentially increasing access for hundreds of thousands.
Canadian Platform to Offer India-Sourced Ozempic to US
A Canadian pharmacy platform plans to supply US patients with Ozempic sourced from India starting in 2026, creating a new cross-border pharmaceutical channel. Learn the details and implications.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Novo Nordisk Plans Lower-Price Ozempic to Fight Generics
Pharmaceutical giant Novo Nordisk is considering a strategic rebrand of a lower-price version of Ozempic to compete directly with upcoming generic alternatives. Learn about the potential market shift.
Wegovy weight-loss pill launches in U.S. as oral alternative
Novo Nordisk launches Wegovy pill in the U.S., providing a flexible, needle-free option for weight management. Learn about this new alternative to injectable medications.
Doctor on Generic Ozempic: 'Exciting Time for Canada'
Dr. Sue Pedersen advises patients to consult their doctors individually about using generic or brand-name Ozempic. A pivotal moment for diabetes and weight-loss treatment access in Canada.
Generic Ozempic Production Approved in Canada, Supply Delayed
Canadian companies can begin producing generic versions of Ozempic starting next week, but experts warn patients should not expect immediate access due to manufacturing and distribution timelines.
Consumer-Driven Future of GLP-1s: Apps & Social Media
Explore how social media trends and digital health apps are transforming access to GLP-1 medications in Canada, moving beyond traditional healthcare channels.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
First Postpartum Depression Drug Approved in Canada
Health Canada has approved ZURZUVAE, the first drug specifically for moderate to severe postpartum depression, offering new hope for one in five Canadian mothers. Learn about the treatment and its impact.
Novo Nordisk shares jump 8% on U.S. Wegovy pill approval
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
U.S. Approves Pill Version of Popular Weight-Loss Drug
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
FDA Approves Wegovy Weight Loss Pill
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
B.C. reviews funding for costly cholesterol drug alternative
B.C. is deciding whether to fund Leqvio, a $9,000-per-year drug for genetic high cholesterol patients intolerant to statins. The decision follows new national recommendations.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Sai Life Sciences Releases 2024-25 Sustainability Report
Indian CRDMO leader Sai Life Sciences publishes its latest sustainability report, detailing progress on climate action, renewable energy, and community impact. Read the full findings.
Lilly pill keeps weight off after injectable drugs in trial
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Moderna gets $54.3M funding for bird flu vaccine
Moderna secures major funding to develop a bird flu vaccine, highlighting a global push to prepare for potential pandemics. Read about the coalition's investment.
Chronic pain patients face medication shortages in Canada
Canadians with chronic pain describe the daily struggle of navigating nationwide shortages of essential pain control medications. Learn about the personal impact and ongoing supply issues.
Quebec Pharmacist Powers Expansion Slow to Roll Out
The expansion of Quebec pharmacists' prescribing powers, announced to improve healthcare access, is experiencing significant implementation delays. Learn about the causes and impacts.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Pfizer 2026 profit forecast below expectations
Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.
Fake Viagra, Cialis pills seized in Toronto store
Health Canada has seized counterfeit erectile dysfunction medications from a Toronto convenience store. Learn the risks and how to protect yourself from dangerous fake drugs.
Hims & Hers Acquires Livewell for Canadian Expansion
U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch
Eli Lilly cuts price of obesity drug Zepbound
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
FDA Links Child Deaths to COVID Vaccine, Plans Changes
An FDA official's internal memo reveals at least 10 child deaths linked to COVID-19 vaccines, prompting proposed vaccine policy reforms and stricter authorization requirements.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Boehringer Ingelheim Names New Board Member for IT
Boehringer Ingelheim announces Harsha Deshmukh's appointment to Board of Managing Directors for IT and Global Business Services effective February 2026.
Page 2 of 4
